Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients
======================================================================================================================================

* Hardev Pandha
* Kevin Harrington
* Christy Ralph
* Alan Melcher
* Mark Grose
* Darren Shafren